Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-415540

Principal Accounting Officer sold 13 shares at $10.56 ($137)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bowen Matthew Principal Accounting Officer 2026-10-05 Sale −13 $10.56 $137 25,891 D: show line 1 in the form
Open-market sales · 13 sh · avg $10.56 · $137
Loading xslF345X06/ownership.xml…